Install
Healthcare technology news, life science current events
- 64articles · 30d
- 12+ hour agolatest article
- Aug 16, 2026earliest in window
- 94%with images
- 341avg words
- Health & Wellness 56
- Medical 45
- Health 38
- Finance & Business 17
- Economy, Business & Finance 16
- Science & Technology 7
- Business & Industrial 4
- News 4
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Is Radiology at a Structural Breaking Point? What Will Move It to a Better Future?
5+ day, 21+ hour ago (520+ words) Radiology sits at the center of modern medicine and often serves as the bridge between clinical symptoms and treatment decisions. Globally, an estimated 3.6 billion diagnostic imaging exams are performed yearly. In the U.S., annual volume exceeds 250 million procedures, with spending topping…...
GSK Pays $110M for Phase 1-Ready Hutchmed Asset in a New Class of Cancer Drugs
6+ day, 21+ hour ago (433+ words) GSK gained rights to a Hutchmed antibody-targeted therapy conjugate, or ATTC. This new type of targeted therapy blocks two cancer-driving proteins and will initially be developed for lung, colorectal, and pancreatic cancers. GSK has experience with cancer therapies that use…...
Thyme Care Raises $125M, Launches New Oncology Parent Entity
1+ week, 4+ day ago (353+ words) Thyme Care's Series E round was led by Morgan Health and included participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures and a16z Bio + Health. Thyme Care, an oncology company,…...
Merck, Moderna Personalized mRNA Cancer Therapy Achieves a First for Melanoma
3+ week, 4+ day ago (367+ words) Merck and Moderna said intismeran autogene, an mRNA cancer vaccine that prompts an immune response to proteins expressed by a patient’s tumors, met the main goal of a pivotal test in melanoma. It’s the most advanced trial in a 50/50 partnership…...